Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neonatal: later-stage trial registry
2 of 4 indexed Neonatal trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Neonatal: 4 US clinical trials tracked, 2 recruiting.
Neonatal is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is NICHD Neonatal Research Network, running 2 of these trials.
Enrollment posture brief
Registry condition neonatal
OPEN 2 | RECR 50% | LATE 1 | EARLY 0 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Neonatal lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neonatal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neonatal is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Neonatal Platelet Transfusion Threshold Trial
NICHD Neonatal Research Network
NCT06676904
Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU
Mayo Clinic
NCT07351799
The Budesonide in Babies (BiB) Trial
NICHD Neonatal Research Network
NCT04545866
Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU
University of Alabama at Birmingham
NCT04354467
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neonatal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neonatal trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neonatal page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Neonatal trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NICHD Neonatal Research Network sponsors the most Neonatal trials on record, review their full trial history before evaluating a specific study. See NICHD Neonatal Research Network's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neonatal condition card totals 4 registered trials; most-linked intervention urine neutrophil gelatinase -associated lipocalin; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.